HEADER HYDROLASE/HYDROLASE INHIBITOR 23-MAY-18 6DIL
TITLE HIV-1 PROTEASE WITH SINGLE MUTATION L76V IN COMPLEX WITH TIPRANAVIR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HIV-1 PROTEASE;
COMPND 3 CHAIN: A, B;
COMPND 4 ENGINEERED: YES;
COMPND 5 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;
SOURCE 3 ORGANISM_TAXID: 11676;
SOURCE 4 GENE: POL;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)
KEYWDS ANTIVIRAL AGENTS, PROTEIN-INHIBITOR STRUCTURES, HIV DRUG RESISTANCE,
KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR A.E.WONG-SAM,Y.-F.WANG,I.T.WEBER
REVDAT 3 11-OCT-23 6DIL 1 REMARK LINK
REVDAT 2 18-DEC-19 6DIL 1 REMARK
REVDAT 1 17-OCT-18 6DIL 0
JRNL AUTH A.WONG-SAM,Y.F.WANG,Y.ZHANG,A.K.GHOSH,R.W.HARRISON,I.T.WEBER
JRNL TITL DRUG RESISTANCE MUTATION L76V ALTERS NONPOLAR INTERACTIONS
JRNL TITL 2 AT THE FLAP-CORE INTERFACE OF HIV-1 PROTEASE.
JRNL REF ACS OMEGA V. 3 12132 2018
JRNL REFN ESSN 2470-1343
JRNL PMID 30288468
JRNL DOI 10.1021/ACSOMEGA.8B01683
REMARK 2
REMARK 2 RESOLUTION. 1.48 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : SHELXL-97
REMARK 3 AUTHORS : G.M.SHELDRICK
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.48
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.77
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6
REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF).
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.166
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.163
REMARK 3 FREE R VALUE (NO CUTOFF) : 0.214
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1937
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 38864
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).
REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.156
REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.153
REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.203
REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1706
REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 34216
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1510
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 67
REMARK 3 SOLVENT ATOMS : 146
REMARK 3
REMARK 3 MODEL REFINEMENT.
REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1713.8
REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00
REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 32
REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL
REMARK 3 NUMBER OF RESTRAINTS : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 ANGLE DISTANCES (A) : 0.029
REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000
REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.028
REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.052
REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.060
REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.014
REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004
REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.054
REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.083
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED: NULL
REMARK 3
REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL
REMARK 3 SPECIAL CASE: NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R
REMARK 3 (NO CUTOFF) BY ?
REMARK 4
REMARK 4 6DIL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-MAY-18.
REMARK 100 THE DEPOSITION ID IS D_1000234717.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 07-OCT-11
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.4
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 22-BM
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : Y
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38910
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.470
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6
REMARK 200 DATA REDUNDANCY : 4.000
REMARK 200 R MERGE (I) : 0.08800
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.47
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.52
REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9
REMARK 200 DATA REDUNDANCY IN SHELL : 3.70
REMARK 200 R MERGE FOR SHELL (I) : 0.49900
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.400
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 3NU3
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 54.84
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5 M NACL, 0.1 M NAOAC, PH 5.4, 5%
REMARK 280 DMSO, 30% CRYOPROTECTANT, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.30200
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.20150
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.30200
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.20150
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 6320 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9320 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 57 CD - NE - CZ ANGL. DEV. = 18.5 DEGREES
REMARK 500 ARG A 57 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES
REMARK 500 ARG B 87 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 NA A 501 NA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP A 60 O
REMARK 620 2 HOH A 605 O 98.2
REMARK 620 3 HOH A 622 O 103.0 72.4
REMARK 620 4 HOH A 630 O 77.1 170.6 100.5
REMARK 620 5 HOH A 647 O 168.1 87.6 88.6 98.5
REMARK 620 6 HOH A 651 O 99.6 100.3 157.0 88.5 69.1
REMARK 620 N 1 2 3 4 5
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue NA A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 502
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 503
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 504
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue TPV B 201
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 202
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 203
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 204
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 6DIF RELATED DB: PDB
REMARK 900 WILD TYPE WITH TPV
REMARK 900 RELATED ID: 6DJ1 RELATED DB: PDB
REMARK 900 RELATED ID: 6DJ2 RELATED DB: PDB
DBREF 6DIL A 1 99 UNP Q5RZ08 Q5RZ08_9HIV1 1 99
DBREF 6DIL B 1 99 UNP Q5RZ08 Q5RZ08_9HIV1 1 99
SEQADV 6DIL LYS A 7 UNP Q5RZ08 GLN 7 ENGINEERED MUTATION
SEQADV 6DIL ILE A 33 UNP Q5RZ08 LEU 33 ENGINEERED MUTATION
SEQADV 6DIL ILE A 63 UNP Q5RZ08 LEU 63 ENGINEERED MUTATION
SEQADV 6DIL ALA A 67 UNP Q5RZ08 CYS 67 ENGINEERED MUTATION
SEQADV 6DIL VAL A 76 UNP Q5RZ08 LEU 76 ENGINEERED MUTATION
SEQADV 6DIL ALA A 95 UNP Q5RZ08 CYS 95 ENGINEERED MUTATION
SEQADV 6DIL LYS B 7 UNP Q5RZ08 GLN 7 ENGINEERED MUTATION
SEQADV 6DIL ILE B 33 UNP Q5RZ08 LEU 33 ENGINEERED MUTATION
SEQADV 6DIL ILE B 63 UNP Q5RZ08 LEU 63 ENGINEERED MUTATION
SEQADV 6DIL ALA B 67 UNP Q5RZ08 CYS 67 ENGINEERED MUTATION
SEQADV 6DIL VAL B 76 UNP Q5RZ08 LEU 76 ENGINEERED MUTATION
SEQADV 6DIL ALA B 95 UNP Q5RZ08 CYS 95 ENGINEERED MUTATION
SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL VAL VAL GLY
SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE
SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL VAL VAL GLY
SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE
HET NA A 501 1
HET CL A 502 1
HET GOL A 503 6
HET ACT A 504 4
HET TPV B 201 84
HET CL B 202 1
HET GOL B 203 6
HET GOL B 204 6
HETNAM NA SODIUM ION
HETNAM CL CHLORIDE ION
HETNAM GOL GLYCEROL
HETNAM ACT ACETATE ION
HETNAM TPV N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-
HETNAM 2 TPV PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-
HETNAM 3 TPV (TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
HETSYN TPV TIPRANAVIR
FORMUL 3 NA NA 1+
FORMUL 4 CL 2(CL 1-)
FORMUL 5 GOL 3(C3 H8 O3)
FORMUL 6 ACT C2 H3 O2 1-
FORMUL 7 TPV C31 H33 F3 N2 O5 S
FORMUL 11 HOH *146(H2 O)
HELIX 1 AA1 GLY A 86 THR A 91 1 6
HELIX 2 AA2 GLN A 92 GLY A 94 5 3
HELIX 3 AA3 GLY B 86 THR B 91 1 6
SHEET 1 AA1 4 GLN A 2 ILE A 3 0
SHEET 2 AA1 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3
SHEET 3 AA1 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98
SHEET 4 AA1 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97
SHEET 1 AA2 8 TRP A 42 GLY A 49 0
SHEET 2 AA2 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43
SHEET 3 AA2 8 HIS A 69 VAL A 77 -1 O ALA A 71 N ILE A 64
SHEET 4 AA2 8 VAL A 32 ILE A 33 1 N ILE A 33 O VAL A 76
SHEET 5 AA2 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32
SHEET 6 AA2 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85
SHEET 7 AA2 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20
SHEET 8 AA2 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14
SHEET 1 AA3 8 LYS B 43 GLY B 49 0
SHEET 2 AA3 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43
SHEET 3 AA3 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66
SHEET 4 AA3 8 VAL B 32 ILE B 33 1 N ILE B 33 O VAL B 76
SHEET 5 AA3 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32
SHEET 6 AA3 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85
SHEET 7 AA3 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20
SHEET 8 AA3 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14
LINK O ASP A 60 NA NA A 501 1555 1555 2.33
LINK NA NA A 501 O HOH A 605 1555 1555 2.44
LINK NA NA A 501 O HOH A 622 1555 1555 2.34
LINK NA NA A 501 O HOH A 630 1555 1555 2.51
LINK NA NA A 501 O HOH A 647 1555 1555 2.71
LINK NA NA A 501 O HOH A 651 1555 1555 2.24
SITE 1 AC1 6 ASP A 60 HOH A 605 HOH A 622 HOH A 630
SITE 2 AC1 6 HOH A 647 HOH A 651
SITE 1 AC2 3 THR A 74 ASN A 88 HOH A 662
SITE 1 AC3 2 LYS A 45 MET A 46
SITE 1 AC4 3 ARG A 8 HOH A 611 TPV B 201
SITE 1 AC5 32 ARG A 8 LEU A 23 ASP A 25 GLY A 27
SITE 2 AC5 32 ALA A 28 ASP A 29 ASP A 30 ILE A 47
SITE 3 AC5 32 GLY A 48 GLY A 49 ILE A 50 VAL A 82
SITE 4 AC5 32 ILE A 84 ACT A 504 HOH A 601 ARG B 8
SITE 5 AC5 32 LEU B 23 ASP B 25 GLY B 27 ALA B 28
SITE 6 AC5 32 ASP B 29 ASP B 30 ILE B 47 GLY B 48
SITE 7 AC5 32 GLY B 49 ILE B 50 PRO B 81 VAL B 82
SITE 8 AC5 32 GOL B 203 HOH B 301 HOH B 302 HOH B 320
SITE 1 AC6 1 TRP B 6
SITE 1 AC7 8 HOH A 611 GLY B 27 ALA B 28 ASP B 29
SITE 2 AC7 8 GLY B 48 TPV B 201 HOH B 301 HOH B 320
SITE 1 AC8 6 TRP A 6 ARG B 87 ASN B 88 THR B 91
SITE 2 AC8 6 HOH B 318 HOH B 327
CRYST1 58.604 86.403 46.156 90.00 90.00 90.00 P 21 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017064 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011574 0.000000 0.00000
SCALE3 0.000000 0.000000 0.021666 0.00000